Literature DB >> 26045755

Clinical characteristics and peripheral T cell subsets in Parkinson's disease patients with constipation.

Yuhua Chen1, Meiling Yu2, Xiaolin Liu1, Hongdang Qu1, Qiming Chen1, Weidong Qian1, Daoxiang Wei1, Wenfang Xu1, Bo Ma1, Wei Wu1.   

Abstract

Constipation is frequently reported in Parkinson's disease (PD). We evaluated the characteristics of patients with PD and constipation and explored the role of T cell subsets in PD-associated constipation. One hundred and two patients with PD treated at the First Affiliated Hospital of Bengbu Medical College were enrolled in this study between January 2012 and October 2013. All patients completed KESS questionnaires and constipation was rated. The proportions of peripheral blood Thl7 and Treg cells were assessed by flow cytometry in 45 patients. Colonoscopies were performed in six patients. Thirty-one patients with PD reported slow-transit constipation (STC), 15 rectal evacuation disorder (RED) and 33 mixed constipation (Mixed). STC most frequently occurred before onset of PD motor symptoms, while Mixed occurred before or after motor symptoms, and RED occurred most frequently after motor symptoms. CD4+ T cell infiltration in the colonic mucosa was observed in patients with PD and constipation. The frequency of Th17 and Treg cells in patients with PD and constipation was significantly higher than in those without constipation (P<0.001). Among patients with PD and constipation, the frequency of Th17 and Treg cells in STC was the highest. However, there was no difference in the ratio of Th17/Tregs between the patients with PD with and without constipation, or patients with PD and different types of constipations (P>0.05). Constipation reported before the onset of PD motor symptoms was most often STC or Mixed, and PD constipation may be associated with immune activation in the colonic mucosa.

Entities:  

Keywords:  CD4+ T cells; Parkinson’s disease; Th17 cells; Treg cells; constipation

Mesh:

Year:  2015        PMID: 26045755      PMCID: PMC4440064     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

Review 1.  FOXP3 and RORγt: transcriptional regulation of Treg and Th17.

Authors:  Zuojia Chen; Fang Lin; Yayi Gao; Zhiyuan Li; Jing Zhang; Yue Xing; Zihou Deng; Zhengju Yao; Andy Tsun; Bin Li
Journal:  Int Immunopharmacol       Date:  2010-11-23       Impact factor: 4.932

2.  Pancolonic spatiotemporal mapping reveals regional deficiencies in, and disorganization of colonic propagating pressure waves in severe constipation.

Authors:  P G Dinning; N Zarate; L M Hunt; S E Fuentealba; S D Mohammed; M M Szczesniak; D Z Lubowski; S L Preston; P D Fairclough; P J Lunniss; S M Scott; I J Cook
Journal:  Neurogastroenterol Motil       Date:  2010-12       Impact factor: 3.598

3.  Flow cytometric detection of human regulatory T cells.

Authors:  Barbara Fazekas de St Groth; Erhua Zhu; Suzanne Asad; Loretta Lee
Journal:  Methods Mol Biol       Date:  2011

Review 4.  Pathophysiology of evacuation disorders.

Authors:  P J Lunniss; M A Gladman; M A Benninga; S S Rao
Journal:  Neurogastroenterol Motil       Date:  2009-12       Impact factor: 3.598

Review 5.  Can "functional" constipation be considered as a form of enteric neuro-gliopathy?

Authors:  Gabrio Bassotti; Vincenzo Villanacci
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

6.  Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.

Authors:  Thibaud Lebouvier; Michel Neunlist; Stanislas Bruley des Varannes; Emmanuel Coron; Anne Drouard; Jean-Michel N'Guyen; Tanguy Chaumette; Maddalena Tasselli; Sébastien Paillusson; Mathurin Flamand; Jean-Paul Galmiche; Philippe Damier; Pascal Derkinderen
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

7.  Medical records documentation of constipation preceding Parkinson disease: A case-control study.

Authors:  R Savica; J M Carlin; B R Grossardt; J H Bower; J E Ahlskog; D M Maraganore; A E Bharucha; W A Rocca
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

8.  The role of the novel Th17 cytokine IL-26 in intestinal inflammation.

Authors:  J Dambacher; F Beigel; K Zitzmann; E N De Toni; B Göke; H M Diepolder; C J Auernhammer; S Brand
Journal:  Gut       Date:  2008-05-15       Impact factor: 23.059

9.  Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.

Authors:  Taye H Hamza; Cyrus P Zabetian; Albert Tenesa; Alain Laederach; Jennifer Montimurro; Dora Yearout; Denise M Kay; Kimberly F Doheny; Justin Paschall; Elizabeth Pugh; Victoria I Kusel; Randall Collura; John Roberts; Alida Griffith; Ali Samii; William K Scott; John Nutt; Stewart A Factor; Haydeh Payami
Journal:  Nat Genet       Date:  2010-08-15       Impact factor: 38.330

10.  Control of TH17 cells occurs in the small intestine.

Authors:  Enric Esplugues; Samuel Huber; Nicola Gagliani; Anja E Hauser; Terrence Town; Yisong Y Wan; William O'Connor; Anthony Rongvaux; Nico Van Rooijen; Ann M Haberman; Yoichiro Iwakura; Vijay K Kuchroo; Jay K Kolls; Jeffrey A Bluestone; Kevan C Herold; Richard A Flavell
Journal:  Nature       Date:  2011-07-17       Impact factor: 49.962

View more
  15 in total

1.  Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.

Authors:  Madelyn C Houser; Jianjun Chang; Stewart A Factor; Eric S Molho; Cyrus P Zabetian; Erin M Hill-Burns; Haydeh Payami; Vicki S Hertzberg; Malú G Tansey
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

Review 2.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

Review 3.  Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner.

Authors:  Wenbin Liu; Meiyang Fan; Wen Lu; Wenhua Zhu; Liesu Meng; Shemin Lu
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 4.  Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.

Authors:  Alexander Grotemeyer; Rhonda Leah McFleder; Jingjing Wu; Jörg Wischhusen; Chi Wang Ip
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

Review 5.  T Lymphocytes in Parkinson's Disease.

Authors:  Elena Contaldi; Luca Magistrelli; Cristoforo Comi
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 6.  Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection.

Authors:  Pascal Derkinderen; François Cossais; Adrien de Guilhem de Lataillade; Laurène Leclair-Visonneau; Michel Neunlist; Sébastien Paillusson; Roberto De Giorgio
Journal:  J Neural Transm (Vienna)       Date:  2021-11-24       Impact factor: 3.850

7.  Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson's Disease Patients: Search for a Disease Indicator.

Authors:  Likun Yang; Changfeng Guo; Jie Zhu; Yi Feng; Weiliang Chen; Zhizhong Feng; Dan Wang; Shibai Sun; Wei Lin; Yuhai Wang
Journal:  Med Sci Monit       Date:  2017-06-18

8.  Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.

Authors:  Charles R Schutt; Howard E Gendelman; R Lee Mosley
Journal:  Mol Neurodegener       Date:  2018-05-21       Impact factor: 14.195

Review 9.  Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.

Authors:  Francesca Garretti; Dritan Agalliu; Cecilia S Lindestam Arlehamn; Alessandro Sette; David Sulzer
Journal:  Front Immunol       Date:  2019-02-25       Impact factor: 7.561

Review 10.  Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence.

Authors:  Elisa Storelli; Niccolò Cassina; Emanuela Rasini; Franca Marino; Marco Cosentino
Journal:  Front Neurol       Date:  2019-01-24       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.